Thrivent Financial for Lutherans Has $81.76 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Thrivent Financial for Lutherans reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 139,828 shares of the healthcare conglomerate's stock after selling 1,898 shares during the period. Thrivent Financial for Lutherans' holdings in UnitedHealth Group were worth $81,755,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group during the third quarter worth approximately $27,000. Macroview Investment Management LLC grew its position in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock worth $28,000 after buying an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the second quarter worth $31,000. Global Wealth Strategies & Associates boosted its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. Finally, Signature Resources Capital Management LLC boosted its position in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 18 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $2.58 during mid-day trading on Monday, hitting $589.65. The company's stock had a trading volume of 2,577,075 shares, compared to its average volume of 3,883,119. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $542.64 billion, a P/E ratio of 38.29, a P/E/G ratio of 1.74 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock's fifty day moving average price is $582.84 and its two-hundred day moving average price is $549.98.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the business posted $6.56 EPS. The company's revenue for the quarter was up 9.2% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's payout ratio is presently 54.72%.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on UNH. KeyCorp initiated coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an "overweight" rating and a $675.00 price objective for the company. Truist Financial reaffirmed a "buy" rating and set a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Tuesday, November 12th. TD Cowen lifted their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a "buy" rating in a research note on Friday, October 18th. Finally, Stephens decreased their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating for the company in a research report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.